The Consumer Electronics Show has become an early-year trend barometer for health tech, and this year was no different as immersive tech took center stage at the annual Las Vegas event.
The 2019 pipeline report: Changing the treatment paradigm
With less than 14% of Phase I to III drug candidates winning FDA approval, unforeseen roadblocks can derail even the most promising clinical research programs.
Two drugs in the pipeline representing unique marketing challenges
With pharma facing ongoing scrutiny of its pricing practices, medical marketers are increasingly asked to demonstrate the superior value of new therapies. High-profile candidates in immunology, pain management, and melanoma challenge marketers well in advance of launch.
As CAR-Ts go from candidates to brands, what’s the marketing strategy?
